Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Soluble transferrin receptor and mutations in hemochromatosis and transferrin genes in a general Catalan population.

Bérez V, Camps J, Arija V, Aranda N, Fernández-Ballart J, Vilella E, Figuera L, Ferré N, Joven J.

Clin Chim Acta. 2005 Mar;353(1-2):205-8.

PMID:
15698609
2.

Genetic screening for HFE hemochromatosis in 6,020 Danish men: penetrance of C282Y, H63D, and S65C variants.

Pedersen P, Milman N.

Ann Hematol. 2009 Aug;88(8):775-84. doi: 10.1007/s00277-008-0679-1.

PMID:
19159930
3.

Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause?

Aguilar-Martinez P, Bismuth M, Picot MC, Thelcide C, Pageaux GP, Blanc F, Blanc P, Schved JF, Larrey D.

Gut. 2001 Jun;48(6):836-42.

4.

H63D homozygotes with hyperferritinaemia: Is this genotype, the primary cause of iron overload?

de Diego C, Opazo S, Murga MJ, Martínez-Castro P.

Eur J Haematol. 2007 Jan;78(1):66-71.

PMID:
17042772
5.
7.

Soluble transferrin receptor in hemochromatosis patients during phlebotomy therapy.

Piéroni L, Mekhloufi F, Thiolières JM, Hainque B, Herson S, Jardel C.

Clin Chim Acta. 2005 Mar;353(1-2):61-6.

PMID:
15698591
8.

The soluble transferrin receptor as a marker of iron homeostasis in normal subjects and in HFE-related hemochromatosis.

Brandão M, Oliveira JC, Bravo F, Reis J, Garrido I, Porto G.

Haematologica. 2005 Jan;90(1):31-7.

9.

Effects of exercise on soluble transferrin receptor and other variables of the iron status.

Schumacher YO, Schmid A, König D, Berg A.

Br J Sports Med. 2002 Jun;36(3):195-9.

10.

Hemochromatosis gene mutations, liver function tests and iron status in alcohol-dependent patients admitted for detoxification.

Robinson G, Narasimhan S, Weatherall M, Beasley R.

J Gastroenterol Hepatol. 2007 Jun;22(6):852-4.

PMID:
17565641
11.

Population-based study of the relationship between mutations in the hemochromatosis (HFE) gene and arthritis.

Sherrington CA, Knuiman MW, Divitini ML, Bartholomew HC, Cullen DJ, Olynyk JK.

J Gastroenterol Hepatol. 2006 Mar;21(3):595-8.

PMID:
16638105
12.

Circulating soluble transferrin receptor according to glucose tolerance status and insulin sensitivity.

Fernández-Real JM, Moreno JM, López-Bermejo A, Chico B, Vendrell J, Ricart W.

Diabetes Care. 2007 Mar;30(3):604-8.

PMID:
17327328
13.

Phenotype variation in C282Y homozygotes for the hemochromatosis gene.

Lazarescu A, Snively BM, Adams PC.

Clin Gastroenterol Hepatol. 2005 Oct;3(10):1043-6.

PMID:
16234052
14.

Serum soluble transferrin receptor concentrations are increased in central obesity. Results from a screening programme for hereditary hemochromatosis in men with hyperferritinemia.

Freixenet N, Remacha A, Berlanga E, Caixàs A, Giménez-Palop O, Blanco-Vaca F, Bach V, Baiget M, Sánchez Y, Félez J, González-Clemente JM.

Clin Chim Acta. 2009 Feb;400(1-2):111-6. doi: 10.1016/j.cca.2008.10.019. Erratum in: Clin Chim Acta. 2014 Sep 25;436:351.

PMID:
19000667
15.

Hemochromatosis-causing mutations C282Y and H63D are not risk factors for atherothrombotic cerebral infarction.

Hruskovicová H, Milanez T, Kobal J, Potisk KP, Petrovic D, Peterlin B.

Med Sci Monit. 2005 Jul;11(7):BR248-52.

PMID:
15990686
16.

Defective trafficking and localization of mutated transferrin receptor 2: implications for type 3 hereditary hemochromatosis.

Wallace DF, Summerville L, Crampton EM, Subramaniam VN.

Am J Physiol Cell Physiol. 2008 Feb;294(2):C383-90.

17.

The role of Hemochromatosis C282Y and H63D mutations in the development of type 2 diabetes mellitus in Greece.

Habeos IG, Psyrogiannis A, Kyriazopoulou V, Psilopanagiotou A, Papavassiliou AG, Vagenakis AG.

Hormones (Athens). 2003 Jan-Mar;2(1):55-60.

18.

Analysis of the genes for transferrin, transferrin receptor as well as H and L subunits of ferritin in idiopathic hemochromatosis.

Sampietro M, Cairo G, Piperno A, Fargion S, Bardella L, Schiaffonati L, Fiorelli G.

Ric Clin Lab. 1987 Jul-Sep;17(3):209-14.

PMID:
3671994
19.

Hemochromatosis due to mutations in transferrin receptor 2.

Roetto A, Daraio F, Alberti F, Porporato P, Calì A, De Gobbi M, Camaschella C.

Blood Cells Mol Dis. 2002 Nov-Dec;29(3):465-70.

PMID:
12547237
20.

Increased urinary excretion of 8-iso-prostaglandin F2alpha in patients with HFE-related hemochromatosis: a case-control study.

Kom GD, Schwedhelm E, Nielsen P, Böger RH.

Free Radic Biol Med. 2006 Apr 1;40(7):1194-200.

PMID:
16545687

Supplemental Content

Support Center